Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis, and treatment

American Journal of Medicine

Volumn 103, Issue 6, 1997, Pages 536-540

  Tefferi, Ayalew ^a   Nichols, William L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; DESMOPRESSIN; IMMUNOGLOBULIN G;

AUTOIMMUNITY; BLOOD ANALYSIS; CLINICAL FEATURE; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; VON WILLEBRAND DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; VON WILLEBRAND DISEASE;

EID: 0031460262     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00239-8     Document Type: Review

References (93)

1. Simone JV, Cornet JA, Abildgaard CF. Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood. 31:1968;806-812.
2. Ingram GI, Kingston PJ, Leslie J, Bowie EJ. Four cases of acquired von Willebrand's syndrome. Br J Haematol. 21:1971;189-199.
3. Gouault-Heilmann M, Dumont MD, Intrator L, et al. Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor. J Clin Pathol. 32:1979;1030-1035.
4. Jakway JL. Acquired von Willebrand's disease. Hematol Oncol Clin North Am. 6:1992;1409-1419.
5. Angchaisuksiri P, Atichartakarn V, Pathepchotiwong K, et al. Experience with factor VIII:C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital. Southeast Asian J Trop Med Public Health. 24:(suppl 1):1993;152-158.
6. Poole-Wilson P. Acquired von Willebrand's syndrome and systemic lupus erythematosus. Proc R Soc Med. 65:1972;561-562.
7. Pizzuto J, Ambriz R, de la Paz Reyna M, et al. Acquired von Willebrand's syndrome during autoimmune disorder. Thromb Haemost. 42:1980;1523-1528.
8. Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol. 46:1994;141-146.
9. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet. 1:1987;1007-1009.
10. Blesing NE, Hambley H, McDonald G. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J. 66:1990;474-476.
11. Coccia MR, Barnes HV. Hypothyroidism and acquired von Willebrand disease. J Adolesc Health. 12:1991;152-154.
12. Levesque H, Borg JY, Cailleux N, et al. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med. 2:1993;287-288.
13. Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy. J Pediatr. 125:1994;911-913.
14. Tjan-Heijnen VC, Harthoorn-Lasthuizen EJ, Kurstjens RM, Koolen MI. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease. Neth J Med. 44:1994;91-94.
15. Mant MJ, Hirsh J, Gauldie J, et al. Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy. Blood. 42:1973;429-436.
16. Meyer D, Frommel D, Larrieu MJ, Zimmerman TS. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion. Blood. 54:1979;600-606.
17. Gan TE, Sawers RJ, Koutts J. Pathogenesis of antibody-induced acquired von Willebrand syndrome. Am J Hematol. 9:1980;363-371.
18. Sampson BM, Greaves M, Malia RG, Preston FE. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol. 54:1983;233-244.
19. Mannucci PM, Lombardi R, Bader R, et al. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders of benign monoclonal gammopathies. Blood. 64:1984;614-621.
20. Fricke WA, Brinkhous KM, Garris JB, Roberts HR. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody. Blood. 66:1985;562-569.
21. Lopez-Fernandez MF, Lopez-Berges C, Martin R, et al. Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy. Scand J Haematol. 36:1986;302-308.
22. Castaman G, Rodeghiero F, Di Bona E, Ruggeri M. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy. Blut. 58:1989;211-213.
23. Stewart AK, Glynn MF. Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone. Postgrad Med J. 66:1990;560-562.
24. Castaman G, Tosetto A, Rodeghiero F. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate. Am J Hematol. 41:1992;132-136.
25. Scrobohaci ML, Daniel MT, Levy Y, et al. Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease. Br J Haematol. 84:1993;471-475.
26. Bovill EG, Ershler WB, Golden EA, et al. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor. Am J Clin Pathol. 85:1986;115-123.
27. Takahashi H, Nagayama R, Tanabe Y, et al. DDAVP in acquired von Willebrand syndrome associated with multiple myeloma. Am J Hematol. 22:1986;421-429.
28. Mohri H, Noguchi T, Kodama F, et al. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor. Am J Clin Pathol. 87:1987;663-668.
29. Drouin J, Lillicrap DP, Izaguirre CA, et al. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis. Am J Clin Pathol. 92:1989;471-478.
30. Richard C, Cuadrado MA, Prieto M, et al. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol. 35:1990;114-117.
31. Mazurier C, Parquet-Gernez A, Descamps J, et al. Acquired von Willebrand's syndrome in the course of Waldenström's disease. Thromb Haemost. 44:1980;115-118.
32. Silberstein LE, Abrahm J, Shattil SJ. The efficacy of intensive plasma exchange in acquired von Willebrand's disease. Transfusion. 27:1987;234-237.
33. Zettervall O, Nilsson IM. Acquired von Willebrand's disease caused by a monoclonal antibody. Acta Med Scand. 204:1978;521-528.
34. Goudemand J, Samor B, Caron C, et al. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment. Br J Haematol. 68:1988;227-233.
35. van Genderen PJ, Michiels JJ, Bakker JJ, van't Veer MB. Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease. Vox Sang. 67:1994;14-17.
36. Handin RI, Martin V, Moloney WC. Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome. Blood. 48:1976;393-405.
37. Joist JH, Cowan JF, Zimmerman TS. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder. NEJM. 298:1978;988-991.
38. Tran-Thang C, Mannucci PM, Schneider P, et al. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma. Br J Haematol. 61:1985;307-314.
39. Rao KP, Kizer J, Jones TJ, et al. Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med. 112:1988;47-50.
40. van Genderen PJ, Vink T, Michiels JJ, et al. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood. 84:1994;3378-3384.
41. Tefferi A, Hanson CA, Kurtin PJ, et al. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells. Br J Haematol. 96:1997;850-853.
42. Wautier JL, Levy-Toledano S, Caen JP. Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia. Scand J Haematol. 16:1976;128-134.
43. Roussi JH, Houbouyan LL, Alterescu R, et al. Acquired von Willebrand's syndrome associated with hairy cell leukaemia. Br J Haematol. 46:1980;503-506.
44. Brownlee RE Jr, Shockley WW. Acquired von Willebrand's syndrome. Therapeutic and diagnostic implications. Arch Otolaryngol Head Neck Surg. 117:1991;106-108.
45. Duran-Suarez JR, Pico M, Zuazu J, et al. Acquired von Willebrand's disease caused by a chronic granulocytic leukaemia. Br J Haematol. 1981;48:173-175. Letter.
46. Budde U, Schaefer G, Mueller N, et al. Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood. 64:1984;981-985.
47. Casonato A, Fabris F, Zancan L, Girolami A. Acquired type I von Willebrand's disease in a patient with essential thrombocytosis. Acta Haematol. 75:1986;188-189.
48. Lazarchick J, Pappas AA, Kizer J, Hall SA. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens. Am J Hematol. 21:1986;305-314.
49. Mohri H. Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol. 22:1986;391-401.
50. Ball J, Malia RG, Greaves M, Preston FE. Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor. Br J Haematol. 65:1987;95-100.
51. Mohri H. Acquired von Willebrand disease in patients with polycythemia rubra vera. Am J Hematol. 26:1987;135-146.
52. Mohri H, Ohkubo T. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera. Acta Haematol. 78:1987;258-264.
53. Raman BK, Sawdyk M, Saeed SM. Essential thrombocythemia with acquired von Willebrand's disease. Am J Clin Pathol. 88:1987;102-106.
54. Murakawa M, Okamura T, Tsutsumi K, et al. Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment. Acta Haematol. 87:1992;83-87.
55. van Generen PJ, Michiels JJ, van der Poel-van de Luytgaarde SC, van Vliet HH. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol. 69:1994;81-84.
56. Benson PJ, Peterson LC, Hasegawa DK, Smith CM II. Abnormality of von Willebrand factor in patients with hemoglobin E-beta degrees thalassemia. Am J Clin Pathol. 93:1990;395-399.
57. Lazarchick J, Green C. Acquired von Willebrand's disease following bone marrow transplantation. Ann Clin Lab Sci. 24:1994;211-215.
58. Noronha PA, Hruby MA, Maurer HS. Acquired von Willebrand disease in a patient with Wilms' tumor. J Pediatr. 95:1979;997-999.
59. Scott JP, Montgomery RR, Tubergen DG, Hays T. Acquired von Willebrand's disease in association with Wilms' tumor: regression following treatment. Blood. 58:1981;665-669.
60. Han P, Lou J, Wong HB. Wilms' tumour with acquired von Willebrand's disease. Aust Paediatr J. 23:1987;253-255.
61. Coppes MJ, Zandvoort SW, Sparling CR, et al. Acquired von Willebrand disease in Wilms' tumor patients. J Clin Oncol. 10:1992;422-427.
62. Delmer A, Horellou MH, Brechot JM, et al. Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins. Am J Hematol. 40:1992;151-152.
63. Facon T, Caron C, Courtin P, et al. Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haematol. 80:1992;488-494.
64. Mogilner JG, Fonseca J, Davies MR. Congenital mesoblastic nephroma associated with acquired von Willebrand disease: a case report. Isr J Med Sci. 31:1995;441-443.
65. Nowak-Gottl U, Kehrel B, Budde U, et al. Acquired von Willebrand disease in malignant peripheral neuroectodermal tumor (PNET). Med Pediatr Oncol. 25:1995;117-118.
66. Rosborough TK, Swaim WR. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia. Am J Med. 65:1978;96-100.
67. McGrath KM, Johnson CA, Stuart JJ. Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia. Am J Med. 67:1979;693-696.
68. Cass AJ, Bliss BP, Bolton RP, Cooper BT. Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease. Br J Surg. 67:1980;639-641.
69. Wood GM, Losowsky M. "Angiodysplasia" of the tongue with acquired von Willebrand's disease. Postgrad Med J. 58:1982;37-38.
70. Rahmani R, Rozen P, Papo J, et al. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia. Isr J Med Sci. 26:1990;504-509.
71. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet. 340:1992;35-37.
72. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood. 67:1986;758-761.
73. Richard C, Sedano MC, Cuadrado MA, et al. Acquired von Willebrand's syndrome associated with hydatid disease of the spleen - disappearance after splenectomy. Thromb Haemost. 52:1984;90-93.
74. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor. Am J Hematol. 49:1995;83-86.
75. Sanfelippo MJ, Suberviola PD, Geimer NF. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol. 88:1987;653-655.
76. Dalrymple-Hay M, Aitchison R, Collins P, et al. Hydroxyethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol. 14:1992;209-211.
77. Lazarchick J, Conroy JM. The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Ann Clin Lab Sci. 25:1995;306-309.
78. Kreuz W, Linde R, Funk M, et al. Induction of von Willebrand disease type I by valproic acid. Lancet. 1990;335:1350-1351. Letter.
79. Igarashi N, Miura M, Kato E, et al. Acquired von Willebrand's syndrome with lupus-like serology. Am J Pediatr Hematol Oncol. 11:1989;32-35.
80. Brody JI, Haidar ME, Rossman RE. A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy. NEJM. 300:1979;408-410.
81. Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci USA. 88:1991;4761-4765.
82. Russell SD, Roth GJ. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. Blood. 81:1993;1787-1791.
83. Takahashi H, Murata M, Moriki T, et al. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease. Blood. 85:1995;727-733.
84. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 16:1990;1-20.
85. Lind SE. The bleeding time does not predict surgical bleeding. Blood. 77:1991;2547-2552.
86. Triplett DA. Laboratory diagnosis of von Willebrand's disease. Mayo Clin Proc. 66:1991;832-840.
87. Rick ME. Laboratory diagnosis of von Willebrand's disease. Clin Lab Med. 14:1994;781-794.
88. Werner EJ, Abshire TC, Giroux DS, et al. Relative value of diagnostic studies for von Willebrand disease. J Pediatr. 121:1992;34-38.
89. Heath AB, Barrowcliffe TW. Standardisation of factor VIII-V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma. Thromb Haemost. 68:1992;155-159.
90. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight vWF forms. Am J Clin Pathol. 104:1995;264-271.
91. Macik BG, Gabriel DA, White GC II, et al. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome. Arch Pathol Lab Med. 112:1988;143-146.
92. White LA, Chisholm M. Gastro-intestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immuno-globulin where substitution treatments failed. Br J Haematol. 84:1993;332-334.
93. Van Genderen PJ, Papatsonis DN, Michiels JJ, et al. High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. Postgrad Med J. 70:1994;916-920.